Exemption number (b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.Additionally, a review of the complaint history identified no similar incidents reported from this lot.The reported patient effects of heart failure and death as listed in the mitraclip system instructions for use are a known possible complications associated with mitraclip procedures.This event was further reviewed by an abbott vascular medial affairs director, who stated that: given the successful procedure and the time between the procedure and the event, device issue is unlikely, and the most probable cause of death was disease progression with worsening heart failure.All available information was investigated, and a definitive cause for the reported heart failure could not be determined; however, hospitalization was an outcome of patient experiencing heart failure.It is possible that patient death was an outcome of procedural circumstances and post procedure patient anatomical challenges; however, this cannot be confirmed.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
Study patient (b)(6).This is filed for patient death.It was reported that the patient underwent a mitraclip procedure on (b)(6) 2019, treating functional mitral regurgitation (mr) of grade 4+.Two mitraclips were implanted and the mr was reduced to grade 1+.On (b)(6) 2019, the patient was re-hospitalized with worsening heart failure and died on (b)(6) 2019.It is unknown if the patient¿s death is related to a device issue.No additional information was provided.
|